Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 29;44(7):2887-2902.
doi: 10.3390/cimb44070199.

Insights into the Uses of Traditional Plants for Diabetes Nephropathy: A Review

Affiliations
Review

Insights into the Uses of Traditional Plants for Diabetes Nephropathy: A Review

Haleema Shahin D H et al. Curr Issues Mol Biol. .

Abstract

Diabetic nephropathy (DN) is a serious kidney illness characterized by proteinuria, glomerular enlargement, reduced glomerular filtration, and renal fibrosis. DN is the most common cause of end-stage kidney disease, accounting for nearly one-third of all cases of diabetes worldwide. Hyperglycemia is a major factor in the onset and progression of diabetic nephropathy. Many contemporary medicines are derived from plants since they have therapeutic properties and are relatively free of adverse effects. Glycosides, alkaloids, terpenoids, and flavonoids are among the few chemical compounds found in plants that are utilized to treat diabetic nephropathy. The purpose of this review was to consolidate information on the clinical and pharmacological evidence supporting the use of a variety of medicinal plants to treat diabetic nephropathy.

Keywords: antioxidant; diabetic nephropathy; medicinal plants; streptozotocin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Pathophysiology of diabetes nephropathy. Abbreviations: Advanced glycosylated end products (AGEs), glomerular basement membrane (GBM), protein kinase C (PKC), transforming growth factor beta(TGF-β).

Similar articles

Cited by

References

    1. Sun H., Saeedi P., Karuranga S., Pinkepank M., Ogurtsova K., Duncan B.B., Stein C., Basit A., Chan J.C., Mbanya J.C., et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022;183:109–119. doi: 10.1016/j.diabres.2021.109119. - DOI - PMC - PubMed
    1. Zhang S., Ge Q., Chen L., Chen K. Studies of the Anti-Diabetic Mechanism of Puerarialobata Based on Metabolomics and Network Pharmacology. Processes. 2021;9:1245. doi: 10.3390/pr9071245. - DOI
    1. Magee C., Grieve D.J., Watson C.J., Brazil D.P. Diabetic nephropathy: A tangled web tounweave. Cardiovasc. Drugs Ther. 2017;31:579–592. doi: 10.1007/s10557-017-6755-9. - DOI - PMC - PubMed
    1. Schena F.P., Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 2005;16:S30–S33. doi: 10.1681/ASN.2004110970. - DOI - PubMed
    1. Vinod P.B. Pathophysiology of diabetic nephropathy. Clin. Queries Nephrol. 2012;1:121–126. doi: 10.1016/S2211-9477(12)70005-5. - DOI

LinkOut - more resources